BCSF Bain Capital Specialty Finance Forecast, Technical & Fundamental Analysis

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BCSF's RSI Oscillator exited the oversold zone, 11 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 46%.

The Moving Average Convergence Divergence (MACD) for BCSF just turned positive on October 27, 2026. Looking at past instances where BCSF's MACD turned positive, the stock continued to rise in 25 of 55 cases over the following month. The odds of a continued upward trend are 45%.

BCSF moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BCSF crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.

Following a +3.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where BCSF advanced for three days, in 140 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 44%.

BCSF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCSF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.

The Aroon Indicator for BCSF entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. BCSF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 63 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.

The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.669) is normal, around the industry mean (2.412). P/E Ratio (11.253) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (1.047) is also within normal values, averaging (1.319). Dividend Yield (0.151) settles around the average of (0.270) among similar stocks. P/S Ratio (9.166) is also within normal values, averaging (15.694).